Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies

February 2024

Pawel Swietach, Department of Physiology, Anatomy and Genetics 
Do mutations in SLC4A3 expose a druggable vulnerability in the adaptation of endometrial cancer to hypoxia?

Valentine Macaulay, Jinseon (Selena) Kim, Nuffield Department of Surgical Sciences
The WINGMEN trial: investigating effects of IGF blockade on the tumour immune microenvironment of localised prostate cancer

Anna Rose, Department of Paediatrics
Exploiting FAM111A protease to selectively target ALT cancers

Berna Bou Tayeh, Yang Shi, Ludwig Institute for Cancer Research 
Unveiling the epigenetic regulators of Natural Killer cell exhaustion and their use for cancer immunotherapy

Keaton Jones, Nuffield Department of Surgical Sciences 

High Intensity Focused Ultrasound (HIFU) as an immune primer in pancreatic cancer

Eileen Parkes, Department of Oncology 

Immunosuppression in oesophageal adenocarcinoma

Olaf Ansorge, Nuffield Department of Clinical Neurosciences
Novel Analytical Technologies for Precision Medicine in Rare Sarcomas – A Pilot Study on Mesenchymal Chondrosarcoma

Adam Wilkinson & Yavor Bozhilov, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine 
Investigating the functional consequences of gaining chromosomes inhuman blood stem cells

Lennard Lee, David Anaya, Tim Elliott, Rob Watson, Miles Weatherseed, Nuffield Department of Medicine 
The Oxford Cancer Vaccine Project Mouse POEM pioneer study